Circulating nucleic acids, including DNA and RNA, hold a promising potential for the diagnosis of a wide range of clinical indications, including complex diseases. In the innovation field of in-vitro diagnostics, new methods for processing circulating nucleic acids are therefore being developed and applied for liquid biopsy.